TY - JOUR
T1 - Factors associated with daily opioid use among aged home care clients
T2 - a cross-sectional analysis of Resident Assessment Instrument data
AU - Mörttinen-Vallius, Heidi
AU - Hartikainen, Sirpa
AU - Huhtala, Heini
AU - Seinelä, Lauri
AU - Jämsen, Esa
N1 - Funding Information:
The study was financially supported by the Finnish Medical Foundation and the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (grant 9V009).
Funding Information:
HMV has received a research grant from the Finnish Medical Foundation. SH has received lecture fees (unrelated to this study) from Astellas Pharma. HH and LS declare they have no conflicts of interest. EJ has received lecture fees (unrelated to this study) from Nutricia, Orion Pharma, and Finnish medical associations.
PY - 2022
Y1 - 2022
N2 - Purpose: To examine which client characteristics and other factors, including possible adverse effects, identified in the Resident Assessment Instrument—Home Care (RAI-HC) are associated with daily opioid use among aged home care clients. Methods: The study sample comprised 2584 home care clients aged ≥ 65 years, of which 282 persons used opioids daily. Clients using opioids less than once daily were excluded. The cross-sectional data were gathered from each client’s first assessment with the RAI-HC during 2014. Multivariable logistic regression was used to study associations of daily opioid use with the clients’ characteristics and symptoms. Results: Cognitive impairment was associated with less frequent opioid use after adjusting for pain-related diseases, disabilities and depressive symptoms (OR 0.43, 95% CI 0.32–0.58). The association was not explained by the estimated severity of pain. Osteoporosis, cancer within previous 5 years and greater disabilities in Instrumental Activities of Daily Living (IADL) were associated with daily opioid use regardless of the estimated severity of pain. Depressive symptoms and Parkinson’s disease were associated with daily opioid use only among clients with cognitive impairment, and disabilities in Activities of Daily Living, cancer, arthritis, fractures and pressure ulcers only among clients without cognitive impairment. Constipation was the only adverse effect associated with daily opioid use. Conclusion: The pain of home care clients with cognitive impairment may not be treated optimally, whereas there might be prolonged opioid use without a sufficient evaluation of current pain among clients with osteoporosis, cancer within previous 5 years and disabilities in IADLs.
AB - Purpose: To examine which client characteristics and other factors, including possible adverse effects, identified in the Resident Assessment Instrument—Home Care (RAI-HC) are associated with daily opioid use among aged home care clients. Methods: The study sample comprised 2584 home care clients aged ≥ 65 years, of which 282 persons used opioids daily. Clients using opioids less than once daily were excluded. The cross-sectional data were gathered from each client’s first assessment with the RAI-HC during 2014. Multivariable logistic regression was used to study associations of daily opioid use with the clients’ characteristics and symptoms. Results: Cognitive impairment was associated with less frequent opioid use after adjusting for pain-related diseases, disabilities and depressive symptoms (OR 0.43, 95% CI 0.32–0.58). The association was not explained by the estimated severity of pain. Osteoporosis, cancer within previous 5 years and greater disabilities in Instrumental Activities of Daily Living (IADL) were associated with daily opioid use regardless of the estimated severity of pain. Depressive symptoms and Parkinson’s disease were associated with daily opioid use only among clients with cognitive impairment, and disabilities in Activities of Daily Living, cancer, arthritis, fractures and pressure ulcers only among clients without cognitive impairment. Constipation was the only adverse effect associated with daily opioid use. Conclusion: The pain of home care clients with cognitive impairment may not be treated optimally, whereas there might be prolonged opioid use without a sufficient evaluation of current pain among clients with osteoporosis, cancer within previous 5 years and disabilities in IADLs.
KW - Aged
KW - Cognitive impairment
KW - Home care
KW - Opioids
KW - Resident Assessment Instrument
U2 - 10.1007/s41999-021-00533-0
DO - 10.1007/s41999-021-00533-0
M3 - Article
AN - SCOPUS:85109892152
VL - 13
JO - EUROPEAN GERIATRIC MEDICINE
JF - EUROPEAN GERIATRIC MEDICINE
SN - 1878-7649
IS - 1
ER -